Alpine Immune Sciences Inc (ALPN)
64.60
+0.01
(+0.02%)
USD |
NASDAQ |
May 03, 16:00
64.60
0.00 (0.00%)
After-Hours: 20:00
Alpine Immune Sciences Total Return Level: 64.59 for May 2, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 02, 2024 | 64.59 |
May 01, 2024 | 64.60 |
April 30, 2024 | 64.59 |
April 29, 2024 | 64.70 |
April 26, 2024 | 64.56 |
April 25, 2024 | 64.62 |
April 24, 2024 | 64.57 |
April 23, 2024 | 64.55 |
April 22, 2024 | 64.58 |
April 19, 2024 | 64.55 |
April 18, 2024 | 64.43 |
April 17, 2024 | 64.46 |
April 16, 2024 | 64.50 |
April 15, 2024 | 64.42 |
April 12, 2024 | 64.37 |
April 11, 2024 | 64.40 |
April 10, 2024 | 47.04 |
April 09, 2024 | 38.94 |
April 08, 2024 | 38.53 |
April 05, 2024 | 34.91 |
April 04, 2024 | 35.33 |
April 03, 2024 | 38.11 |
April 02, 2024 | 39.21 |
April 01, 2024 | 40.22 |
March 28, 2024 | 39.64 |
Date | Value |
---|---|
March 27, 2024 | 38.65 |
March 26, 2024 | 37.45 |
March 25, 2024 | 37.55 |
March 22, 2024 | 39.34 |
March 21, 2024 | 41.60 |
March 20, 2024 | 40.23 |
March 19, 2024 | 39.95 |
March 18, 2024 | 35.47 |
March 15, 2024 | 36.38 |
March 14, 2024 | 35.89 |
March 13, 2024 | 36.61 |
March 12, 2024 | 36.45 |
March 11, 2024 | 35.38 |
March 08, 2024 | 35.93 |
March 07, 2024 | 37.00 |
March 06, 2024 | 38.55 |
March 05, 2024 | 37.47 |
March 04, 2024 | 36.66 |
March 01, 2024 | 36.00 |
February 29, 2024 | 35.22 |
February 28, 2024 | 34.92 |
February 27, 2024 | 35.96 |
February 26, 2024 | 34.75 |
February 23, 2024 | 33.92 |
February 22, 2024 | 33.11 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.151
Minimum
Mar 17 2020
64.70
Maximum
Apr 29 2024
10.35
Average
8.68
Median
Aug 18 2021
Total Return Level Benchmarks
Vertex Pharmaceuticals Inc | 400.16 |
Eliem Therapeutics Inc | 8.34 |
Regeneron Pharmaceuticals Inc | 937.61 |
Vera Therapeutics Inc | 43.50 |
Eyenovia Inc | 0.932 |